Author

O. Schmid

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

T. Stoeger· 2 shared A. Doryab· 1 shared A. O. Yildirim· 1 shared C. Argyo· 1 shared C. Ballester-Lopez· 1 shared C. H. Mayr· 1 shared C. Meyer-Schwickerath· 1 shared C. Morrone· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

T. Stoeger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell circuits underlying nanomaterial specific respiratory toxicology

C. Voss, L. Han, M. Ansari, M. Strunz, V. Haefner, C. Ballester-Lopez, I. Angelidis, C. H. Mayr, T. Berthing, T. Conlon, Q. Liu, H. Ren, Q. Zhou, O. Schmid, A. O. Yildirim, , T. Stoeger

This study uses single-cell RNA-sequencing to analyze how different nanomaterials affect lung inflammation in mice, identifying cell type-specific responses and mechanisms.

bioRxiv · Feb 10, 2024 · PreprintPharmacology & Toxicology

Organ-restricted vascular delivery of nanoparticles for lung cancer therapy

D. A. Bolukbas, S. Datz, C. Meyer-Schwickerath, C. Morrone, A. Doryab, D. Goessl, M. Vreka, L. Yang, C. Argyo, S. H. van Rijt, M. Lindner, O. Eickelberg, T. Stoeger, O. Schmid, S. Lindstedt, , S. Meiners

This study introduces organ-restricted vascular delivery to enhance nanoparticle targeting to lung tumors, showing improved cellular uptake compared to systemic or intratracheal administration.

bioRxiv · Mar 5, 2020Pharmacology & Toxicology